Skip to content
10-K

Annual Report

Golden Ally Lifetech Group, Inc.

0001493152-23-012706

← back to feed
Filed
Apr 18, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Apr 17, 2023 7.41B sh
Operating Cash Flow FY 2022 · Dec 31, 2022 −$6.09M
Operating Cash Flow restated FY 2022 · Dec 31, 2021 −$57.57K
Cash And Equivalents FY 2022 · Dec 31, 2022 $581.97K
Cash And Equivalents restated FY 2022 · Dec 31, 2021 $3M
Stockholders Equity FY 2022 · Dec 31, 2022 $1.59M
Stockholders Equity restated FY 2022 · Dec 31, 2021 $2.99M
Current Liabilities FY 2022 · Dec 31, 2022 $98.32K
Current Liabilities restated FY 2022 · Dec 31, 2021 $5K
Total Liabilities FY 2022 · Dec 31, 2022 $129.32K
Total Liabilities restated FY 2022 · Dec 31, 2021 $5K
Current Assets FY 2022 · Dec 31, 2022 $1.62M
Current Assets restated FY 2022 · Dec 31, 2021 $3M
Total Assets FY 2022 · Dec 31, 2022 $1.72M
Total Assets restated FY 2022 · Dec 31, 2021 $3M
Eps Basic FY 2022 · Dec 31, 2022 $0.00
Eps Basic restated FY 2022 · Dec 31, 2021 $0.00
Sga Expense FY 2022 · Dec 31, 2022 $274.38K
Sga Expense restated FY 2022 · Dec 31, 2021 $70
Rd Expense FY 2022 · Dec 31, 2022 $98.45K
Net Income FY 2022 · Dec 31, 2022 −$6.07M
Net Income restated FY 2022 · Dec 31, 2021 −$57.57K
Operating Income FY 2022 · Dec 31, 2022 −$6.07M
Operating Income restated FY 2022 · Dec 31, 2021 −$57.57K